Analysis of Drug Use in Non-Ventilator Covid-19 Patients at Bangil Hospital

Background: Coronavirus Disease 2019 (Covid-19) is an infectious disease. Common signs and symptoms of Covid-19 infection include acute respiratory distress such as fever, cough shortness breath. Analysis drug use in Non-Ventilator patients needs to be carried out provide overview therapy currently being used based on the Management Guidelines Edition 3rd because so far, there has not been a single type that received marketing authorization for therapy. Objectives: This study aims determine patient profiles, therapeutic outcomes, suitability with edition, quantity antibiotic using DDD/100 patient-days method antivirals. Methods: The this observational design which was analyzed descriptively retrospective data collection. Result: Based profile COVID-19 patients, are 31 types classes. most consumed drugs were antibacterial (91%) analgesics (91%), followed by vitamins (89%) supplements (85%). value, widely antibiotics Azithromycin. Conclusion: patient's at time admission hospital 44% moderate 56% severe. condition discharge from degree antivirals more recovered returned home improvements percentages 84.1% 88.64%, respectively.